A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized COVID-19 Treatments - Poll - MDSpire

A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized COVID-19 Treatments

  • By

  • Margaret A Maglione

  • Jeffrey D Klausner

  • Patricia K Wirnkar

  • Ivan Fallarme

  • Rozhin Lak

  • Kimny Sysawang

  • Ning Fu

  • Sachi Yagyu

  • Aneesa Motala

  • Danica Tolentino

  • Susanne Hempel

  • April 11, 2025

  • 0 min

Share

Original Source(s)

A Rapid Systematic Review of U.S. Food and Drug Administration-Authorized COVID-19 Treatments

  • by Margaret A Maglione, Jeffrey D Klausner, Patricia K Wirnkar, Ivan Fallarme, Rozhin Lak, Kimny Sysawang, Ning Fu, Sachi Yagyu, Aneesa Motala, Danica Tolentino, Susanne Hempel

  • April 11, 2025

Related Content

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

MEK1/2 inhibitor ATR-002 reshapes host transcriptome and modulates immune regulatory genes in SARS-CoV-2 infection

Ensitrelvir Reduced COVID After Household Exposure

In SCORPIO-PEP, symptomatic COVID-19 occurred in 3% vs 9% of household contacts by day 10.